AU2003275709A1 - Therapeutic agent for spinal canal stenosis - Google Patents
Therapeutic agent for spinal canal stenosisInfo
- Publication number
- AU2003275709A1 AU2003275709A1 AU2003275709A AU2003275709A AU2003275709A1 AU 2003275709 A1 AU2003275709 A1 AU 2003275709A1 AU 2003275709 A AU2003275709 A AU 2003275709A AU 2003275709 A AU2003275709 A AU 2003275709A AU 2003275709 A1 AU2003275709 A1 AU 2003275709A1
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic agent
- spinal canal
- canal stenosis
- stenosis
- spinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000031481 Pathologic Constriction Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000037804 stenosis Diseases 0.000 title 1
- 230000036262 stenosis Effects 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-314084 | 2002-10-29 | ||
JP2002314084A JP2006096665A (en) | 2002-10-29 | 2002-10-29 | Therapeutic agent for spinal canal stenosis |
PCT/JP2003/013776 WO2004039404A1 (en) | 2002-10-29 | 2003-10-28 | Therapeutic agent for spinal canal stenosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003275709A1 true AU2003275709A1 (en) | 2004-05-25 |
Family
ID=32211603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003275709A Abandoned AU2003275709A1 (en) | 2002-10-29 | 2003-10-28 | Therapeutic agent for spinal canal stenosis |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2006096665A (en) |
AU (1) | AU2003275709A1 (en) |
WO (1) | WO2004039404A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2543315A1 (en) * | 2003-11-13 | 2005-06-02 | The General Hospital Corporation | Methods for treating pain |
US8173642B2 (en) | 2005-10-25 | 2012-05-08 | Shionogi & Co., Ltd. | Aminodihydrothiazine derivatives |
JP5383483B2 (en) | 2007-04-24 | 2014-01-08 | 塩野義製薬株式会社 | Pharmaceutical composition for the treatment of Alzheimer's disease |
AU2008245082B8 (en) | 2007-04-24 | 2012-09-13 | Shionogi & Co., Ltd. | Aminodihydrothiazine derivatives substituted with a cyclic group |
NZ589590A (en) | 2008-06-13 | 2012-05-25 | Shionogi & Co | Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity |
EP2360155A4 (en) | 2008-10-22 | 2012-06-20 | Shionogi & Co | 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity |
MX2012006491A (en) | 2009-12-11 | 2012-07-03 | Shionogi & Co | Oxazine derivative. |
WO2012057247A1 (en) | 2010-10-29 | 2012-05-03 | 塩野義製薬株式会社 | Fused aminodihydropyrimidine derivative |
WO2012057248A1 (en) | 2010-10-29 | 2012-05-03 | 塩野義製薬株式会社 | Naphthyridine derivative |
CN103608345A (en) | 2011-04-26 | 2014-02-26 | 盐野义制药株式会社 | Oxazine derivative and BACE 1 inhibitor containing same |
WO2014065434A1 (en) | 2012-10-24 | 2014-05-01 | Shionogi & Co., Ltd. | Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266594A (en) * | 1992-05-12 | 1993-11-30 | Dawson Valina L | Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity |
GB9425701D0 (en) * | 1994-12-20 | 1995-02-22 | Wellcome Found | Enzyme inhibitors |
WO1996021445A1 (en) * | 1995-01-13 | 1996-07-18 | The General Hospital Corporation | Methods of inhibiting neurodegenerative diseases |
US6110930A (en) * | 1997-04-10 | 2000-08-29 | Ono Pharmaceutical Co., Ltd. | Condensed piperidine compound |
CN1334921A (en) * | 1998-12-04 | 2002-02-06 | 卫福有限公司 | Prostaglandin transporter and apoptosis |
JP3927343B2 (en) * | 2000-01-12 | 2007-06-06 | 株式会社リコー | Automatic document feeder and image reading device |
AU2001262711A1 (en) * | 2000-06-08 | 2001-12-17 | Mitsubishi Pharma Corporation | Cytoprotectors |
-
2002
- 2002-10-29 JP JP2002314084A patent/JP2006096665A/en active Pending
-
2003
- 2003-10-28 WO PCT/JP2003/013776 patent/WO2004039404A1/en not_active Application Discontinuation
- 2003-10-28 AU AU2003275709A patent/AU2003275709A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004039404A1 (en) | 2004-05-13 |
JP2006096665A (en) | 2006-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003254553A1 (en) | Medical implant | |
AU2003253106A1 (en) | Medical implant | |
AU2003232258A1 (en) | Medical implant | |
AU2003243150A1 (en) | Resorption-controllable medical implants | |
AU2003215099A1 (en) | Anterior spinal implant | |
AU2003256813A1 (en) | Medical tele-robotic system | |
EP2295053B8 (en) | Novel 2H-chromen-2-one-3-carboxamides for medical uses | |
AU2003232063A1 (en) | Simulation system for medical procedures | |
AU2003259249A1 (en) | Pyridazinylpiperazine derivatives for treating pain | |
AU2003258298A1 (en) | Medical implants | |
AU2003234929A1 (en) | Therapeutic agent for diabetes | |
AU2003279911A1 (en) | Therapeutic formulations | |
AU2003294318A1 (en) | Therapeutic bioconjugates | |
AU2003210515A1 (en) | Methods for sterilizing tissue | |
AU2003221078A1 (en) | Therapeutic composition for bone infectious disease | |
AU2003275709A1 (en) | Therapeutic agent for spinal canal stenosis | |
AU2003221042A1 (en) | Preventive or therapeutic agent for kidney disease | |
AUPR551301A0 (en) | Monitor for auditory prosthesis | |
AU2003267668A1 (en) | Medical apparatus | |
AU2003221184A1 (en) | Therapeutic agent for endothelial disorder | |
AU2003241154A1 (en) | Navigator-robot for surgical procedures | |
AU2003280767A1 (en) | Remedies for vertebral canal stenosis | |
PL397023A1 (en) | Therapeutic agent for AIDS treatment | |
AU2003223780A1 (en) | Treatment for pompe disease | |
AU2002950443A0 (en) | Spinal implant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |